Equity
AOCI
Medtronic AOCI decreased by 1.3% to -$4.33B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 52.5%, from -$2.84B to -$4.33B. Over 4 years (FY 2021 to FY 2025), AOCI shows a downward trend with a 5.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ3 2026Feb 24, 2026
How to read this metric
High volatility often signals exposure to foreign exchange rates or interest rate fluctuations.
Detailed definition
Accumulated other comprehensive income (AOCI) captures unrealized gains and losses that are excluded from the income sta...
Peer comparison
Highly dependent on the company's global footprint and hedging strategy.
Metric ID:
aociHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.49B | -$3.21B | -$3.04B | -$2.88B | -$2.27B | -$1.94B | -$2.36B | -$3.19B | -$3.5B | -$3.67B | -$3.38B | -$3.46B | -$3.32B | -$3.41B | -$3.25B | -$2.84B | -$4.28B | -$4.6B | -$4.28B | -$4.33B |
| QoQ Change | — | +7.9% | +5.2% | +5.4% | +21.3% | +14.4% | -21.8% | -35.1% | -9.7% | -5.0% | +8.1% | -2.4% | +4.1% | -2.8% | +4.7% | +12.6% | -50.9% | -7.5% | +7.1% | -1.3% |
| YoY Change | — | — | — | — | +35.0% | +39.6% | +22.4% | -10.8% | -54.5% | -89.5% | -43.0% | -8.5% | +5.2% | +7.2% | +3.8% | +17.9% | -29.1% | -35.0% | -31.5% | -52.5% |
Range-$4.6B – -$1.94B
CAGR+4.7%
Avg YoY Growth-14.0%
Median YoY Growth-9.6%
AOCI at Other Companies
Frequently Asked Questions
- What is Medtronic's aoci?
- Medtronic (MDT) reported aoci of -$4.33B in Q4 2025.
- How has Medtronic's aoci changed year-over-year?
- Medtronic's aoci decreased by 52.5% year-over-year, from -$2.84B to -$4.33B.
- What is the long-term trend for Medtronic's aoci?
- Over 4 years (2021 to 2025), Medtronic's aoci has grown at a 5.3% compound annual growth rate (CAGR), from -$3.49B to -$4.28B.
- What does aoci mean?
- Cumulative unrealized gains or losses from market fluctuations not included in net income.